Inactive Instrument

Highlights SEM4 HLDG

Equities

SMFR

US18978W1099

Highlights

Unlock all the news: Be the first to know and act before the market!

Twist Bioscience : SomaLogic Form Partnership to Discover Novel Therapeutic Targets, Antibodies	21-08-18	MT
Update: Sema4 Q2 Net Loss Widens Despite Revenue Boost -- Shares Slump in Pre-Market	21-08-17	MT
SEM4 HLDG : Sema4 Q2 Net Loss Widens Despite Revenue Boost	21-08-16	MT
SEM4 HLDG : Earnings Flash (SMFR) SEMA4 Posts Q2 Revenue $46.9M	21-08-16	MT
SEM4 HLDG : Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights	21-08-16	AQ
SEMA4 HOLDINGS CORP. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events, Financial Statements and Exhibits (form 8-K)	21-07-28	AQ
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company	21-07-22	CI
Mount Sinai Genomics, Inc. completed the acquisition of CM Life Sciences, Inc. from CMLS Holdings LLC, Eli D. Casdin, Keith A. Meister and others in a reverse merger transaction.	21-07-21	CI
Cm Life Sciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-21	CI
CM Life Sciences : and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination	21-07-02	BU
Sema4 : and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement	21-06-10	BU
Cm Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-24	CI
Sema4 : and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger	21-05-06	BU
CM Life Sciences III Raises $552 Million in IPO	21-04-09	MT
Cm Life Sciences, Inc. Reports Earnings Results for the Half Year Ended December 31, 2020	21-03-30	CI
CM Life Sciences II : SomaLogic to Go Public Through Combination With SPAC	21-03-29	MT
CM Life Sciences : SomaLogic to merge with Keith Meister-backed SPAC in $1.23 bln deal	21-03-29	RE
CM Life Sciences : SomaLogic to go public through SPAC merger in $1.23 bln deal	21-03-29	RE
Market Chatter: CM Life Sciences II Reportedly Nears $1.25 Billion SPAC Merger Deal With SomaLogic	21-03-29	MT
SPAC trading pops deflate as 'exuberance and greed' depart	21-03-24	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights SEM4 HLDG

Equities

SMFR

US18978W1099

Highlights

Filters